| Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia. | None |
| Crystallization and preliminary X-ray analysis of the human c-H-ras-oncogene product p21 complexed with GTP analogues. | None |
| Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene. | None |
| Ha-Ras-1 oncogene dosage differentially affects Balb/3T3 cells growth factor requirement and tumorigenicity. | None |
| Transfection of insulin-producing cells with a transforming c-Ha-ras oncogene stimulates phospholipase C activity. | None |
| Human immunodeficiency virus long terminal repeat responds to transformation by the mutant T24 H-ras1 oncogene and it contains multiple AP-1 binding TPA-inducible consensus sequence elements. | None |
| Expression of the H-ras proto-oncogene is controlled by alternative splicing. | None |
| Activation of the c-Ha-ras-1 proto-oncogene by methylation in vitro with alpha-acetoxy-N-nitrosodimethylamine. | None |
| Effects of various chemical agents on the transformation of rat fibroblasts by an activated c-Ha-ras oncogene. | None |
| [Change in the organization of the actin cytoskeleton and extracellular fibronectin in the REF(LT) cell line after a series of successive transfections of the Ha-ras oncogene]. | None |
| Potential role of the human Ha-ras oncogene in the inhibition of gap junctional intercellular communication. | None |
| A transfected H-ras oncogene does not inhibit differentiation of cardiac and skeletal muscle from embryonal carcinoma cells. | None |
| Binding of the 97 kDa glucocorticoid receptor to the 5 upstream flanking region of the mouse c-Ha-ras oncogene. | None |
| In vivo and in vitro effects of v-fos and EJ-Ha-ras oncogene expression in murine epidermal keratinocytes. | None |
| Potentiation of cysteine proteinase-inhibitor activity of full-length Ha-ras oncogene products by denaturation-renaturation. | None |
| Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. | None |
| ras p21 oncoprotein is autoregulated and acts as a potential mediator of insulin action or the H-ras1 promoter. | None |
| The ras oncogene and tumour metastasis: observations on murine cells transfected with activated human c-Ha-ras. | None |
| Two sequence-specific binding proteins from the promoter region of the c-Ha-ras-I oncogene. | None |
| DNA methylation of the Ha-ras-1 oncogene in neoplastic cells. | None |